Finally, analysis of TCGA-GBM datasets showed that among patients expressing higher transcript levels of CD4 and BCL6, those expressing higher levels of memory signature, including IL6RA, TCF7, and BACH2, compared to those expressing lower levels were correlated with better survival (Fig. 6j and Supplementary Data 1). The gene discussed is BCL6; the disease is glioblastoma.